News & Perspective

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Mar 01, 2006

Mar 01, 2006

HHS orders drugs to treat 14 million in flu pandemic

(CIDRAP News) – US health officials announced today they have ordered more than 14 million treatment courses of two antiviral drugs to add to the 5.5 million courses already bought in preparation for a possible influenza pandemic.

Feb 03, 2006

Feb 03, 2006

Latest cases raise WHO's avian flu tally to 161

(CIDRAP News) – The World Health Organization (WHO) tally of human cases of H5N1 avian influenza rose to 161, including 86 deaths, with the final confirmation of 12 cases in Turkey and one in Iraq this week.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»